Tag Archives: bad-request

Biotech NantKwest Stock Surges On 1st Day Of Trading

NantKwest (NK) soared on its first day of trading, after raising $207 million in an upsized initial public offering. NantKwest is in the hot field of immunotherapy, which deploys the patient’s own immune system to fight cancer and other diseases. NantKwest offered 8.3 million shares at 25 each. The initial plan was to offer 7 million shares at 20 to 23. The stock opened at 37, up 48%. In late morning trading, NantKwest was up 35%, near 33.40, in

NantKwest Surges As Biggest Biotech Market Cap IPO

NantKwest (NK) soared on its first day of trading, after raising $207 million in an upsized initial public offering. NantKwest is in the hot field of immunotherapy, which deploys the patient’s own immune system to fight cancer and other diseases. NantKwest offered 8.3 million shares at 25 each. The initial plan was to offer 7 million shares at 20 to 23. The stock opened at 37, up 48%, easing to a close at 34.64, up 39% from the IPO. At its

United Therapeutics Plunges On Q2 Sales Miss

Big-cap biotech United Therapeutics (UTHR) disappointed investors for the second quarter in a row Tuesday, as it missed Q2 estimates and its new drug launch continued to underwhelm. The stock hit a five-month low in early trading on the stock market today . Revenue in the quarter grew 7.6% over the year-earlier quarter to $347.2 million, about $13 million below analysts’ consensus, according to Thomson Reuters. Earnings rose 14% to $2.55 a share,